Aging Analytics Agency Executives Participate in Inaugural Meeting of the All-Party Parliamentary Group for
Longevity in UK Parliament
Aging Analytics Agency Founder Dmitry Kaminskiy Participates in First APPG for Longevity Meeting to Discuss Making Healthy Longevity a Key Priority for the UK Government’s Strategic Agenda
On 7th of March, 2019, Dmitry Kaminskiy (Founder of Aging Analytics Agency, and Co-Founder / Head of International Development for Longevity International UK, the APPG for Longevity Secretariat) and Eric Kihlstrom (Director of Aging Analytics Agency and Head of Industry Collaboration for Longevity International UK, the APPG for Longevity Secretariat) convened with parliamentarians, policy directors and researchers at Room M, Portcullis House, Houses of Parliament, to participate in the inaugural meeting of the All-Party Parliamentary Group for Longevity, and to discuss key goals for the group’s strategic agenda for the coming year.
Key topics covered by Kaminskiy during the meeting included giving an overview of some of the major trends associated with advances in biomedicine, their impact of ageing and on financial systems in particular, and on the need for the group to simultaneously focus on synergetic development of advanced biomedicine to extend Healthy Longevity, the convergence of Artificial Intelligence and Precision Health, and novel financial reform to turn the challenges that threaten the stagnation of the UK’s financial institutions into new markets and opportunities for the betterment of the nation’s economic growth.
Discussions were opened and chaired by the Rt Hon Damian Green MP, former Secretary of State for Work and Pensions, Vice-Chaired by the Rt Hon Norman Lamb MP, Sir Peter Bottomley MP, Jonathan Lord MP, Kevin Foster MP. Secretary was Lord Stone, and the treasurer was Baroness Sally Greengross. Contributors were Sir Peter Bottomley MP, Tina Woods (Longevity International, Annemarie Naylor (Director of Policy & Strategy, Future Care Capital), Joel Charles (Government Relations, FCC), Ami Shpiro (Founder, Innovation Warehouse), Marcos Vega-Hazas (Longevity International), Julien Poulin (Public Affairs Officer, NHS Confederation), Jasmine Storry (Policy Researcher for Rt Hon Damian Green MP) and Baroness Camilla Cavendish (journalist former Conservative Party policy director).
The participants of the discussion agreed on several key points, including:
-
That the challenge the “Silver Tsunami”, presents a clear economic threat, with 10 million people in the UK expected to live to 100 years vs 15,000 people today.
-
That a global shift from treatment to prevention models of medicine is necessary and desirable.
-
That the strength of the grey pound, spending power of the over-50s, is increasing dramatically
-
That there are therefore economic benefits to Healthy Longevity in the population and that any future development planning should be in pursuit of this ‘longevity dividend’, such as by seeking to offer older people economically active, leading longer healthy lives.
-
That this dividend is attainable due to advancements in technologies that will extend healthy lifespan, including the science of ageing, precision, personalised and preventive medicine, AgeTech, etc.
-
That London is a global hub for FinTech, but should also become the major hub for AgeTech companies, novel financial services structured specifically for the interests of elderly expecting to live longer and as active consumers.
By the conclusion of the meeting, a number of key goals and resolutions were agreed upon
-
That the government ought to rename the “Ageing Society Grand Challenge” of its industrial strategy to the more positive name of “Health Longevity”.
-
To produce ideas paper on longevity for discussion in the Houses of Parliament, and draft blueprint for a National Strategy for Healthy Longevity.
-
To seek public support and approval for the pursuit of a longevity dividend.
-
To open the APPG for Longevity’s ongoing discussion on this matter to all relevant stakeholders of industry, including financial services firms, insurance companies, pension funds, biopharma
-
companies, etc.
